The global Extensively Drug-Resistant Tuberculosis (Xdr-Tb) Treatment Market is witnessing a pivotal shift in 2025. As one of the most significant threats to global health security, XDR-TB—a form of TB resistant to nearly all the most effective anti-TB drugs—has spurred a wave of pharmaceutical innovation. In 2025, the market is characterized by a transition from toxic, multi-year inj... https://www.databridgemarketresearch.com/